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Summary The childhood leukaemia incidence rate for the Netherlands was estimated at 3.11 per 100.000
children (aged 0-15 year) per year, based on a complete nation-wide childhood leukaemia registry comprising
the period 1973-1980. Acute lymphocytic leukaemia (ALL) accounted for 82.4% of the patients, acute non-
lymphocytic leukaemia for 13.6% and chronic myeloid leukaemia for 2.9%. ALL occurred more frequently in
boys (sex ratio 1.2). The highest ALL rate was observed in the 3-4 year age group. These figures
corresponded with the data of the Manchester Children's Tumour Registry. Neither the incidence rates
according to year of diagnosis nor the incidence rates according to year of birth showed a significant trend
with time. The total leukaemia incidence rate in urban areas was somewhat higher than in rural areas. While
the direct comparison of the incidence rate between these areas is not significant, the trend over the three
categories of urbanisation is significant.
Childhood leukaemia incidence varies across
different countries. In some an increase in incidence
rates has been noted in recent years (Birch et al.,
1981; Ericsson et al., 1978; Stiller & Draper, 1982)
and in others no time trend was found (Teppo et
al., 1975; Young & Miller, 1975).
The existence of a complete nation-wide
children's leukaemia registry in the Netherlands
provides the opportunity to compare Dutch
incidence rates with those of other countries and to
study trends over age, time and geography.
Materials and methods
The morbidity registry of the Dutch Childhood
Leukaemia Study Group (DCLSG) was established
in 1972. It covers the whole country, which had a
childhood population < 15 y of nearly 3.4 million in
1976 (total population 13.9 million). Nearly 160
paediatricians in the Netherlands collaborate in the
DCLSG in an effort to optimize the treatment of
children with leukaemia. They routinely sent blood
and bone marrow slides of each child with
leukaemia, or under suspicion of this disease to the
laboratory of the DCLSG. These slides are reviewed
according to previously determined criteria by 2
independent experts. Before 1975 the DCLSG used
its own diagnostic criteria based on morphology and
cytochemistry (Sudan Black and Periodic Acid-
Schiff, (PAS)). Since 1975 the French-American-
British (FAB) classification has been used (Van
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Wering & Vissers-Praalder, 1979; Bennet et al.,
1976). The treatment of these children is centrally
coordinated and clinical information is collected
uniformly. In 1980 the completeness of the
morbidity registry was checked by sending a
questionnaire to all paediatricians in the
Netherlands. They were asked to give the names,
dates of birth, dates of diagnosis and sex of all
leukaemia patients they had treated or consulted
between 1973 and 1980. The overall response rate
to the questionaire was 92.6%, and 17 cases,
hitherto unknown, were reported. Bone marrow
slides of 12 of these patients were still available and
the diagnosis of leukaemia could be confirmed at
the DCLSG laboratory. It could be estimated that
a 95.4-99.9% ascertainment of patients had been
achieved in the period 1973-1980.
The leukaemia patients who were accepted for
this study were all <15 y at the time of diagnosis
(i.e. between January 1st, 1973 and January 1st,
1980). The diagnosis was confirmed on bone
marrow slides at the DCLSG laboratory. The date
of the diagnostic bone marrow puncture represents
the date of diagnosis.
Annual incidence rates per 105 children were
calculated by dividing the number of leukaemia
patients per calendar year by the average of the
Netherlands childhood population on January 1st
and December 31st of the year concerned (i.e. an
approximation to the mid-year population). Trends
in incidence rates for the years of diagnosis were
examined by 2 statistical methods: logit analysis
and Spearman's rank correlation test. In the logit
analysis the relation between incidence rate, year of
diagnosis and age at diagnosis was tested (Breslow
& Day. 1980). For the rank correlation test, the
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annual incidence rates were directly standardized to
age (Armitage, 1971). The standard population was
fixed by the smallest childhood population, i.e. the
population in 1979; this yields least statistical
variance when comparisons are made. The same
analyses were also performed on incidence rates per
year of birth. In the Netherlands the degree of
urbanisation for every municipality is known. The
incidence rates of areas with varying urbanisations
were directly standardized to age. The rural
population, being the smallest, was chosen as the
standard. Differences in incidence rates between
urban and rural areas were tested for statistical
significance by calculating the rate difference (RD)
with 95% confidence limits (Rothman & Boice,
1979). Analysis for trend over the 3 categories, of
urbanisation (rural, intermediate urban and urban)
was performed by weighted linear regression
analysis, using the inverse of the variances of the
incidence rates as weights (Snedecor & Cochran,
1980). For this purpose the data for the 7-year
period, 1973-1980, were combined. The
denominator was the mid-year childhood
population in the middle of the total study period
(1976). All the population data were obtained from
the Netherlands Central Bureau of Statistics (CBS,
1973-1980).
Results
Type
The overall leukaemia incidence and the incidence
of the different morphological types are presented in
Table I.
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Table I Total number, incidence rates and frequency
of different morphological types of leukcen,iKl
Number Incidence rate
of per 105 Total
Type patients person years %
ALL 624 2.56 82.4
ANLL 103 0.42 13.6
CML* 22 0.09 2.9
Unclassified 8 1.0
Total 757 3.11 99.9
*Including juvenile and adult type.
Sex
The incidence rates of acute lymphocytic leukaemia
(ALL) for boys and girls were 2.77 and 2.33 per 105
respectively, with a male/female ratio of 1.2.
Age
The age-specific incidence curve of ALL (Figure 1)
showed a peak at the age of 3-4 years for boys as
well as for girls.
Incidence trends according to year ofdiagnosis
The annual incidence rates of all types of
leukaemia, for ALL and for acute non-lymphocytic
leukaemia (ANLL) are shown in Figure 2. In 1979
the incidence rate of ALL was higher than the rates
in the preceding years. However, logit analysis of
the annual incidence rates in the period of study did
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Figure 1 Incidence rate of acute lymphocytic leukaemia (ALL) per
1980 (n=624).
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Figure 2 Incidence rate of childhood leukaemia per
105 person years, 1973-1980.
not show any significant time trend in incidence
neither for all cases, nor for any morphological sub-
group (all P values for analysis, >0.10). Moreover,
a preliminary calculation of the incidence rate in
1980 revealed an overall leukaemia incidence rate of
3.85 per 105 children, similar to the one for 1979.
The incidence rate for ALL in 1980 was 2.98 per
105 and therefore lower than in 1979. The logit
analysis for both sexes seperately showed a
borderline significant trend with time for girls. On
inspection of the date this seemed to be due to the
high 1979 figure. Presumably, 1979 had an
exceptionally high incidence of leukaemia which is
unexplained.
The annual incidence rates of ALL for the three
age-groups 0-4, 5-9 and 10-14 separately, are
shown in Figure 3. The trend in incidence with time
was not significant for any of the three age groups
(all P values, >0.10). For these age groups the
annual incidence rates were also analysed according
to sex. However, no time trend was found.
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Figure 3 Incidence rate of acute lymphocytic
leukaemia per 105 person years by age group, 1973-
1980.
Incidence trend according to year ofbirth
The incidence rates for all types of leukaemias as
well as for ALL per annual birth cohort (1959-
1978) showed no trend with time (P>0.10).
Urbanisation
Leukaemia incidence rates in urban and rural areas
(i.e. residence of patients at time of diagnosis) are
presented in Table II which shows somewhat higher
rates for urban than for rural areas. For all
leukaemia types the rate difference (RD) between
urban and rural areas was not statistically
significant at the 5% level (RD =0.49, 95%
confidence interval -0.39 and 1.39). The trend over
the three categories of urbanisation was significant
(P =0.013).
For ALL neither direct comparison of incidence
rates between urban and rural areas nor the trend
Table II Incidence rates of leukaemia in urban and rural areas
per 105 person years
All leukaemia types ALL
Incidence Incidence
Number rate (s.e.) Number rate (s.e.)
Rural* 90 3.11(0.33) 80 2.77(0.31)
Intermediatet
urban 506 3.42(0.15) 411 2.78(0.14)
Urban$ 161 3.88(0.31) 133 3.21(0.28)
*Rural areas, >20% of the adult population working in
agriculture.
tSmall cities and villages with a population of 5-100 x 103.
tCities with a population of ) 105.
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in incidence over these areas was statistically
significant (all P values for analysis, >0.10).
Discussion
The national leukaemia morbidity registry of the
DCLSG meets all three criteria mentioned by
Young & Miller (1975) to determine the incidence
rate of childhood leukaemia, i.e. a population-based
registry with accurate denominators for every year
of study, nearly complete ascertainment of all cases
and confirmation of the diagnosis on bone marrow
samples of all patients. The cytomorphological
diagnosis is based on previously determined criteria
and made by 2 independent experts. Therefore the
diagnostic homogeneity of the Dutch childhood
leukaemia morbidity registry is unique and the data
presented reflect the true incidence of childhood
leukaemia in the Netherlands.
Type
The leukaemia incidence rates in different countries
are presented in Table III. The Netherlands total
leukaemia incidence rate corresponds with the one
in the Manchester region. The Netherlands
incidence rate of acute lymphocytic leukaemia
(ALL) is 2.56 per 105 compared to 2.61 per 105 in
Manchester, U.K. (Birch et al., 1980). Higher total
leukaemia incidence rates were observed in
Australia, Finland, Sweden and the U.S.A. These
differences might reflect stricter registry criteria in
the Netherland& and Manchester.
In all studies ALL is the most common type of
leukaemia in childhood. In the Manchester region
(Birch et al., 1980) and in the Netherlands it
accounts for 79% and 82.4% respectively.
Sex
In previous studies a predominance of ALL in boys
is found (Birch et al., 1980; Ericsson et al., 1978;
McWhirter & Bacon, 1981; Teppo et al., 1975;
Young & Miller, 1975). According to this finding
the male/female ratio for ALL is 1.2 in the
Netherlands.
Age
The usual age-specific incidence curve of ALL, with
a peak at age 3-4y is also found in this study. This
might suggest that factors in the prenatal period or
the first years of life are of importance in the
aetiology of childhood leukaemia (Birch et al.,
1980).
Incidence trend according to year ofdiagnosis
In the Manchester region an increase in ALL
incidence rates in children since 1970 has been
detected. The increases especially concerned the
youngest age-group of 1-4y (Birch et al., 1981). For
acute myeloid leukaemia no change in incidence
rate was detected. In the U.K. as a whole an
increase in annual registry rates of leukaemia in
boys aged 0-4y was found (Stiller & Draper, 1982).
In Sweden and Finland no increase in the overall
leukaemia incidence rate was established, though in
Sweden significant increases in leukaemia incidence
rates in girls aged 0-4 y and in boys aged 5-9 y
were observed. In Finland the three age groups
were not analysed separately. Neither the annual
Dutch incidence rates of all types of leukaemia, nor
the ALL and ANLL subgroups showed any
significant trend with the time during the period
1973-1980. Only one borderline significant trend
appeared in the ALL incidence rates for girls,
presumably due to a single high figure. The
Table III Leukaemia incidence rates in different countries
Leukaemia incidence
rate per 105
Country Authors person years
The Netherlands 3.11
Manchester region, Birch et al. (1980) 3.31
U.K.
Queensland, McWhirter & Bacon 3.60
Australia (1981)
Finland Teppo et al. (1975) 3.93
Sweden Ericsson et al. 4.18
(1978)
U.S.A. (whites) Young & Miller 4.21
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uniformity of incidence rates might indicate that
environmental factors are of no importance in the
aetiology of leukaemia in children, or alternatively
that these factors are evenly distributed in time,
which suggests that newly-introduced environmental
factors do not influence leukaemia incidence rates in
children (Birch et al., 1980).
Incidence trends according to year ofbirth
Recent analyses of leukaemia registry data in the
U.K. revealed an increased incidence of ALL in
childhood for the birth cohorts after 1964 (Stiller &
Draper, 1982). The increase was only significant for
boys <5 y. The Dutch incidence rates according to
year of birth (1958 until 1978) did not show any
significant trend with time. However, the analysis
was based on small numbers of patients per year of
birth. For this reason boys and girls were not
analysed separately.
Urbanisation
A study in Australia suggested a higher childhood
leukaemia incidence in Brisbane city than its rural
environment (McWhirter & Bacon, 1980). However,
the difference was small. In the U.S.A., leukaemia
mortality was higher in counties with >75% of the
population in urban areas, but this may have been
caused by differences in diagnostic possibilities and
quality of medical care (Blair et al., 1980). In the
Netherlands the total leukaemia incidence rate is
also higher in urban than in rural areas, although
the difference is small. We hesitate to offer an
explanation for this finding.
In summary, the Netherlands childhood
leukaemia incidence rate corresponds well to the
figure in the Manchester region. In contrast with
Manchester and the U.K. as a whole, the incidence
rates per year of diagnosis do not show a trend
with time. The increase of incidence rates according
to year of birth in the U.K. is not found in The
Netherlands. Lastly, in this study there is some
urban-rural gradient too.
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